Durvalumab monoclonal antibody drug. Targets Programmed cell Death-Ligand 1 (PD-L1) and is used in the treatment of cancer (immune checkpoint inhibito

---

Durvalumab monoclonal antibody drug. Targets Programmed cell Death-Ligand 1 (PD-L1) and is used in the treatment of cancer (immune checkpoint inhibitor). Generic name and stylized antibody.

---

Size: 9000px × 3392px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: antibody, biological, biosimilar, biotech, biotechnology, blockade, cancer, carcinoma, cd80, checkpoint, death, disease, drug, durvalumab, immune, immuno-oncology, immunoglobulin, immunology, infusion, inhibitor, injection, inn, ligand, mab, monoclonal, nomenclature, oncology, pd-1, pd-l1, peptide, programmed, protein, tumor, urothelial